Gelomics specializes in advanced 3D tissue culture technologies, primarily through its LunaGel™ system. This innovative platform utilizes photocrosslinking technology to create highly controlled 3D tissue culture models quickly and efficiently, allowing researchers to generate physiologically relevant environments that closely mimic human biology. The LunaGel™ system is designed for ease of use, enabling the creation of complex cell culture models in under 15 minutes without requiring prior experience. Its tunable extracellular matrix (ECM) allows researchers to adjust matrix stiffness by varying light exposure, facilitating the study of both healthy and diseased tissue properties.

The LunaGel™ system is compatible with a wide range of cell types, enhancing experimental versatility. It features biologically active ECMs that promote optimal cell growth and differentiation, as well as responsive degradability that supports cellular remodeling. This technology ensures reliable consistency across different batches, which is crucial for maintaining the integrity of scientific experiments. Gelomics' products are positioned to support various applications, including drug discovery, tissue engineering, and personalized medicine, making them a valuable resource for researchers aiming to advance their studies in cell biology and related fields.

Australia

Gelomics is revolutionizing drug development by enabling the growth of human tissue models in vitro, providing an ethical, cost-effective, and predictive alternative to animal testing. 

Our mission is to accelerate therapeutic breakthroughs, ensuring faster, safer, and more humane medical advancements.

Gelomics

Company Details